Palvella Therapeutics (PVLA) Stock Chart & Stock Price History $36.55 -0.03 (-0.08%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Palvella Therapeutics Stock Price Performance The Palvella Therapeutics (PVLA) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 204.58%. In the past month, the stock has increased 53.38%, reflecting recent market activity. As of the latest close, Palvella Therapeutics traded at $36.55 with a market cap of $404.10 million and volume of 56,129 shares. Receive PVLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-8.33%1 Month Performance+53.38%3 Month Performance+49.43%Year-To-Date Performance+204.58% PVLA Stock Chart for Saturday, August, 2, 2025 PVLA Chart by TradingView Palvella Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$36.58$36.55-0.08%$36.74$34.5756,129 shs$404.10 million07/31/2025$37.44$36.58-2.30%$38.46$36.5090,854 shs$404.58 million07/30/2025$38.88$37.44-3.70%$39.20$36.85256,939 shs$414.09 million07/29/2025$39.87$38.88-2.48%$40.28$37.87332,862 shs$429.86 million07/28/2025$38.62$39.87+3.24%$40.50$37.70251,338 shs$440.96 million07/25/2025$38.63$38.62-0.03%$39.31$37.99169,749 shs$427.14 million07/24/2025$38.43$38.63+0.52%$38.63$37.2268,685 shs$427.25 million07/23/2025$36.00$38.43+6.75%$38.74$35.68331,482 shs$424.88 million07/22/2025$31.00$36.00+16.13%$36.21$31.01644,934 shs$398.16 million07/21/2025$29.51$31.00+5.05%$31.24$29.59129,238 shs$342.86 million Get the Latest News and Ratings for PVLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$31.23$29.51-5.51%$31.50$29.38121,435 shs$326.38 million07/17/2025$28.42$31.23+9.89%$31.36$28.19469,273 shs$345.28 million07/16/2025$27.70$28.42+2.60%$28.47$26.98103,097 shs$314.33 million07/15/2025$27.55$27.70+0.54%$28.07$26.7876,520 shs$306.25 million07/14/2025$26.46$27.55+4.12%$28.15$25.80141,622 shs$304.59 million07/11/2025$26.94$26.46-1.78%$26.89$25.9154,640 shs$292.65 million07/10/2025$25.80$26.94+4.42%$27.00$25.6272,048 shs$297.96 million07/09/2025$24.89$25.80+3.66%$25.83$24.8050,044 shs$285.35 million07/08/2025$24.90$24.89-0.04%$24.99$24.0746,554 shs$275.28 million07/07/2025$24.12$24.90+3.23%$24.93$23.7664,899 shs$275.29 million07/04/2025$24.12$24.12$26.00$23.9040,233 shs$266.67 million07/03/2025$23.83$24.12+1.22%$26.00$23.9040,233 shs$266.77 million07/02/2025$22.67$23.83+5.12%$24.11$22.0379,134 shs$263.56 million07/01/2025$22.54$22.67+0.58%$23.14$21.5596,129 shs$250.73 million Related Companies IMCR Stock Chart TARS Stock Chart ADPT Stock Chart SRPT Stock Chart SDGR Stock Chart EVO Stock Chart EWTX Stock Chart JANX Stock Chart ABCL Stock Chart ANIP Stock Chart Receive PVLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PVLA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palvella Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palvella Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
